- Home
- RYTM vs BEP Comparison
RYTM vs BEP Comparison
Compare RYTM & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- BEP
- Stock Information
- Founded
- RYTM 2008
- BEP 1999
- Country
- RYTM United States
- BEP Canada
- Employees
- RYTM N/A
- BEP N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- BEP Electric Utilities: Central
- Sector
- RYTM Health Care
- BEP Utilities
- Exchange
- RYTM Nasdaq
- BEP Nasdaq
- Market Cap
- RYTM 6.4B
- BEP 7.3B
- IPO Year
- RYTM 2017
- BEP N/A
- Fundamental
- Price
- RYTM $96.03
- BEP $25.80
- Analyst Decision
- RYTM Strong Buy
- BEP Buy
- Analyst Count
- RYTM 13
- BEP 8
- Target Price
- RYTM $101.92
- BEP $31.25
- AVG Volume (30 Days)
- RYTM 553.4K
- BEP 409.3K
- Earning Date
- RYTM 11-04-2025
- BEP 11-07-2025
- Dividend Yield
- RYTM N/A
- BEP 5.72%
- EPS Growth
- RYTM N/A
- BEP N/A
- EPS
- RYTM N/A
- BEP N/A
- Revenue
- RYTM $156,287,000.00
- BEP $6,174,000,000.00
- Revenue This Year
- RYTM $44.69
- BEP $18.12
- Revenue Next Year
- RYTM $63.53
- BEP $5.94
- P/E Ratio
- RYTM N/A
- BEP N/A
- Revenue Growth
- RYTM 53.55
- BEP 12.75
- 52 Week Low
- RYTM $45.91
- BEP $19.29
- 52 Week High
- RYTM $106.52
- BEP $29.56
- Technical
- Relative Strength Index (RSI)
- RYTM 46.64
- BEP 56.87
- Support Level
- RYTM $97.47
- BEP $24.91
- Resistance Level
- RYTM $102.46
- BEP $25.50
- Average True Range (ATR)
- RYTM 3.22
- BEP 0.43
- MACD
- RYTM -1.44
- BEP 0.09
- Stochastic Oscillator
- RYTM 13.52
- BEP 87.42
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.